news

PARSIPPANY, N.J. & JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceuticals USA and related affiliates of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and

Public-private partnership is intended to safeguard Switzerland’s competitive position in pharmaceutical technologies of the future ZURICH & BASEL, Switzerland–(BUSINESS WIRE)–Nanopharmaceutics

Potential New Treatment for Acute Heart Failure Presented at the Heart Failure 2019 Congress TARGET-1 and TARGET-2 trials: safe decongestion

ROCKVILLE, Md.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/allergies?src=hash" target="_blank"gt;#allergieslt;/agt;–Immunomic Therapeutics, Inc. (ITI), a privately held, Maryland-based biotechnology company, announced today that the company will

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Five Prime Therapeutics, Inc. (NASDAQ: FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative

NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) announced today that a Phase 3 study to assess the use of LYRICA® (pregabalin)

DUBLIN–(BUSINESS WIRE)–The “China Pharmaceutical Packaging Industry Report, 2019-2025” report has been added to ResearchAndMarkets.com’s offering. In China, the high-end pharmaceutical

Jakafi is the first and only FDA-approved treatment for patients with steroid-refractory acute graft-versus-host disease (GVHD) WILMINGTON, Del.–(BUSINESS WIRE)–Incyte Corporation

DUBLIN–(BUSINESS WIRE)–The “Healthcare and Pharmaceutical Market in Pakistan” report has been added to ResearchAndMarkets.com’s offering. This report on the Healthcare

LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global antifreeze proteins market is expected to post a CAGR of more than 30% during the